Seres Therapeutics, Inc. Common Stock (MCRB) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
No Form 4 insider filings for MCRB were recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR · 0001609809 (2026-04-11) ↗